Capasso Planning Partners LLC Pfizer Inc Transaction History

Capasso Planning Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $48,304 - $63,056	-1,157 Reduced 21.81%	4,149 $0
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $17,460 - $21,314	399 Added 8.13%	5,306 $232,000
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $5,118 - $6,068	110 Added 2.29%	4,907 $257,000
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $3,156 - $3,911	-69 Reduced 1.42%	4,797 $248,000
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $201,063 - $298,042	4,866 New	4,866 $287,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Capasso Planning Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Capasso Planning Partners LLC with notifications on news.